Latest News

Macular Degeneration Research

Nearly 20 million adults in the U.S. have some form of age-related macular degeneration, almost double the previous estimate of 11 million people, according to a new report. Learn why.

Jan 3, 2023
Press Releases

Global brain and vision research nonprofit BrightFocus Foundation has appointed digital health executive, entrepreneur, and speaker Paul A. Campbell as a new member of its board of directors.

Dec 20, 2022
Alzheimer's Disease Research

A new blood test that could facilitate a more accurate diagnosis of Alzheimer’s during the initial phases of the disease is on the way—rooted in critical early support from Alzheimer’s Disease Research, a program of BrightFocus Foundation. Catching the disease as soon as possible offers affected individuals the greatest gift of all—more time to spend with loved ones and explore disease management and treatment options.

Dec 6, 2022
National Glaucoma Research

A team of BrightFocus-funded scientists has proposed a new explanation and possible new target for treatment in glaucoma that’s unrelated to the common culprit of eye pressure.

Dec 1, 2022
Macular Degeneration Research

David Liao, MD, offers insights into managing and understanding AMD and what forthcoming FDA approval could mean for treatment.

Nov 30, 2022
Alzheimer's Disease Research

Clinical trial results released Nov. 29 for lecanemab, a drug targeting early Alzheimer’s disease, reported a moderate slowing of cognitive decline in patients by 25% through the removal of amyloid-beta (Aβ) in the brain.

Nov 30, 2022
Macular Degeneration Research

If approved, the drug pegcetacoplan would become the first-ever treatment in the U.S. for geographic atrophy, a blinding and advanced form of age-related macular degeneration.

Nov 21, 2022
Alzheimer's Disease Research

More than 75 graduate students, postdoctoral fellows, and other early-career scientists from around the world participated in this year’s BrightFocus Alzheimer’s Fast Track, Nov. 9-11, 2022, in San Diego.

Nov 18, 2022
Alzheimer's Disease Research

Gael Chetelat, PhD, University of Caen-Normandy, France, was honored on Oct. 21, 2022, by Women’s Health Access Matters for her BrightFocus-funded project, “Sex Differences in Risk Profiles Across the Alzheimer’s Disease Continuum.”

Nov 15, 2022
Macular Degeneration Research

In this issue:

  • President’s Corner
  • One-Time Gene Therapy for Wet AMD
  • DNA Modifcation and Gene Expression in AMD
  • And more!
Nov 9, 2022